Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Appl Immunohistochem Mol Morphol. 2021 Aug 1;29(7):506–512. doi: 10.1097/PAI.0000000000000926

Figure 2.

Figure 2.

Alveolar parenchymal α-SMA positivity is significantly reduced in severe asthma (SA) compared to controls, with COPD tending to show similar reductions. Representative α-SMA immunostained images (20X) from a control sample (A), a severe asthma sample (B), and a COPD sample (C). The average percent α-SMA positive pixels in each sample, quantified using the Aperio ImageScope-embedded algorithm. Data expressed as mean ± SD (D).